Pinned Tweet
Exploring advances in Cancer Therapeutics, Targets & Resistance from Acta Materia Medica
Discover cutting-edge research: amm-journal.org/
#CancerResearch #CancerTherapeutics #DrugResistance #Oncology
#WorldPharmacistsDay 2026: Empowering pharmacists for advancing patient care and global health.
#AMM publishes research on drug discovery, pharmaceutical sciences, therapeutic development, & translational medicine supporting the role of pharmacists worldwide.
Visit: amm-journal.org/
R18 blocks dengue virus adsorption via the E protein and suppresses RdRp activity, acting as a dual inhibitor that prevents viral entry and replication. @smu_medical #Virology #Antivirals #GlobalHealth
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
RA fibroblasts show distinct RBP dysregulation.
Dysregulated RBPs drive splicing changes and enhanced FN1 CD44/CXCL12 CXCR4 signaling in RA fibroblasts, offering new therapeutic targets. #Rheumatology #RheumatoidArthritis
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
JM04 shows promise in HF intervention.
JM04 improved cardiac function, reduced fibrosis, and modulated Nrf2/ROS/HIF 1α signaling in HF models. #Cardiology #HeartFailure #Fibrosis
#AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
By modulating chemokine signaling and reducing immune cell recruitment, CTS alleviates coronary inflammation in KD, suggesting a novel anti inflammatory approach. #Cardiology #Inflammation #vasculitis @NJU1902
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
Estrogens trigger cholestasis by disrupting bile transport.
Study shows miR 128 3p suppresses PDZK1, driving MRP2 internalization. Targeting this axis may attenuate cholestatic liver injury. #Hepatology #cholestasis #PDZK1
#AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
HIV 1 capsid insights reshape therapy.
Lenacapavir, the first CA inhibitor, blocks nuclear entry and shows pan stage efficacy with long acting protection. #Virology #Lenacapavir #HIV
#AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
Your research amplified worldwide.
#ActaMateriaMedica invites papers in pharmacy and #PharmaceuticalSciences. Peer-reviewed, #openaccess, no fees.
Know more 👉 amm-journal.org/index.php/ac…
#Mutagenicity testing is vital for safety. DSTOX #Mutagen profiler integrates statistical/expert models, analogue search & ICH classification, delivering guideline-aligned, high-throughput profiling.
#OpenAccess: amm-journal.org/index.php/20…
#AMM #Toxicology #ComputationalToxicology #DrugSafety #QSAR #ICHM7
Check this article link in scienceopen - scienceopen.com/hosted-docum…
This article analyzes five typical use cases to illustrate breakthrough strategies for addressing the critical challenges in new drug R&D, underscoring how interdisciplinary strategies & strategic innovations can drive precision and intelligent R&D. #DrugDiscovery #UndruggableTargets #DrugResistance
#OpenAccess: scienceopen.com/hosted-docum…
Demonstrating that Euphorbia neriifolia L. extract exerts #cardioprotective effects through integrated #antioxidant and signaling modulation.
Read more here👇
#OpenAccess: scienceopen.com/hosted-docum…
Acta Materia Medica retweeted
Does higher selectivity create higher uncertainty for antibody drugs? A new perspective in #CTSjournal explores how context-dependent pharmacology impacts translation, dose selection, & combination therapy in antibody drug development.
Read more: doi.org/10.1111/cts.70556
This review details how comprehensive integration of #ArtificialIntelligence-driven #DrugDiscovery in #TraditionalChineseMedicine (TCM) can systematically model herbal compatibility, predict #Bioactive constituents, and accelerate the clinical translation of complex multi-target formulations.
#OpenAccess: scienceopen.com/hosted-docum…
Acta Materia Medica retweeted
The future of drug discovery isn't just about proving a drug works.
It's about proving why it can outperform the standard of care.
👉 medvolt.ai
#Medvolt #DrugDiscovery #ClinicalTrials #MedGraph #SystemsBiology #AIDrugDiscovery
🤖 Made with AI
Acta Materia Medica retweeted
In a new publishing deal, #Causaly and @Sage_Publishing have announced a partnership to bring full-text scientific peer-reviewed literature into the world of AI-powered drug discovery research.
#publishing #DrugDiscovery #ArtificialIntelligence
hubs.li/Q04r6GZ10